Table 1 Histopathologic descriptions of tumoral specimens
From: MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
Variable | Frequencies (%) |
|---|---|
Nuclear Grade | |
 I | 2 (1.6) |
 II | 48 (38.7) |
 III | 74 (59.7) |
Mitotic Grade | |
 I | 51 (41.1) |
 II | 27 (21.8) |
 III | 46 (37.1) |
Tubule Formation | |
 I | 9 (7.3) |
 II | 40 (32.3) |
 III | 75 (60.5) |
Overall Histologic Grade | |
 I | 18 (14.5) |
 II | 52 (41.9) |
 III | 54 (43.5) |
Molecular Subtypes | |
 Luminal A | 54 (44.3) |
 Luminal B | 34 (27.9) |
 HER2-enriched | 12 (9.8) |
 Triple-Negative | 22 (18.0) |
Lymphovascular Invasion | |
 Negative | 23 (18.5) |
 Positive | 101 (81.5) |
Lymph node Involvement | |
 Negative | 46 (37.4) |
 Positive | 77 (62.6) |
Extra-nodal Extension | |
 Absent | 26 (33.8) |
 Present | 51 (66.2) |
In-situ Carcinoma | |
 Negative | 28 (22.6) |
 Positive | 96 (77.4) |
Estrogen Receptor | |
 Negative | 35 (28.2) |
 Positive | 89 (71.8) |
Progesterone Receptor | |
 Negative | 39 (31.5) |
 Positive | 85 (68.5) |
HER2/Neu | |
 Negative | 95 (76.6) |
 Positive | 29 (23.4) |